PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77021N0214Pharmaceutical - naloxone 4mg NASAL SPRAY — Adapt Pharma Inc

Adapt Pharma Inc holds $753K across 16 federal awards, concentrated at Department of Homeland Security (DHS). This PIID sits alongside 1 related award in the incumbent pipeline.

National Cmop Office (36C770)

Awarding office

Adapt Pharma Inc

Recipient

—

Estimated value

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Adapt Pharma Inc — $90

Contract facts

Federal

Contract number36C77021N0214

Also listed as36C770-21-N-0214

AgencyNational Cmop Office (36C770)

Awarding officeNational Cmop Office (36C770)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentAdapt Pharma Inc

UEIQ1MZNNSQUJ53

PSC6505

PHARMACEUTICAL - NALOXONE 4MG NASAL SPRAY SOLUTION FOR HINES CMOP is a federal award for National Cmop Office (36C770) held by Adapt Pharma Inc. Estimated value —.

PHARMACEUTICAL - NALOXONE 4MG NASAL SPRAY SOLUTION FOR HINES CMOP

Incumbent footprint

Public record

Adapt Pharma Inc — $753K obligated across 16 awards (firm-wide, all agencies) · lead buyer Department of Homeland Security (DHS).

% of firm-wide obligated ($753K) · all agencies

Department of Homeland Security (DHS)$473K · 63%Department of State (DOS)$285K · 38%

Related awards

Same incumbent

19AQMM26P0604

NARCAN NASAL SPRAY DEVICES

$285K

Jun 1, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C77021N0214?

36C77021N0214 (Pharmaceutical - naloxone 4mg NASAL SPRAY) is a National Cmop Office (36C770) award with an estimated value of —, currently held by Adapt Pharma Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-21-N-0214?

36C770-21-N-0214 is the dashed form of PIID 36C77021N0214 (Pharmaceutical - naloxone 4mg NASAL SPRAY), held by Adapt Pharma Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77021N0214?

National Cmop Office (36C770) awarded 36C77021N0214 to Adapt Pharma Inc.

Who is the incumbent on 36C77021N0214?

Adapt Pharma Inc is the incumbent with $753K across 16 related awards in SCOUT’s public footprint.

When does Adapt Pharma Inc’s 36C77021N0214 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C77021N0214 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 1, 2026 · refreshed monthly